INSIGHTS ON SOLID DOSE MANUFACTURING

• Small-Scale Automatic Micro-Dosing Of Powders Into Blisters

  Optimize inline X-ray fill weight verification with precise blister calibration, automated HMI calibration file creation, and 2D code tracking.

• Spray Dry Biologics For Oral Dosage Forms

  Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.

• How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

  With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

• Improving API Solubility Using Hot Melt Extrusion Formulation

  Solubility of active pharmaceutical ingredients (APIs) is a challenge in drug development. Discover how hot melt extrusion with polyvinyl alcohol enhances API solubility and stability to offer improved drug delivery.

• Future Of Pharma Packaging: Trends, Tech, And Patient Solutions

  9/25/2025

  Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

• Engineering Challenges Of Designing Pharmaceutical Isolators

  3/27/2025

  Designing pharmaceutical isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the critical considerations that guarantee drug manufacturing safety and efficiency.

• Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies

  7/15/2026

  In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.

• HPAPIS Production: "Where Micrograms Matters"

  4/13/2026

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

• High Potency APIs And The Evolving Demands Of Drug Development

  4/13/2026

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.